Latisse Ophthalmic Solution

Product Monograph: Latisse® (Bimatoprost Ophthalmic Solution) 0.03% For Hypotrichosis of the Eyelashes Composition and Pharmaceutical Form Each mL of Latisse® contains 0.3 mg bimatoprost (0.03% w/v) as the active ingredient. The sterile, isotonic solution is preserved with benzalkonium chloride 0.05 mg/mL. Inactive components include citric acid, sodium chloride, sodium phosphate dibasic, and purified water. The solution is adjusted to pH 6.8–7.8 using sodium hydroxide or hydrochloric acid. Clinical Pharmacology Bimatoprost belongs to the prostamide class of synthetic analogues structurally related to prostaglandin F2α.